Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2012
06/28/2012US20120165368 Pyrazolopyridine kinase inhibitors
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165328 Inhibitors of b lymphocyte kinase
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/28/2012US20120165310 Ether derivatives of bicyclic heteroaryls
06/28/2012US20120165305 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165296 Bisphosphonate-prodrugs
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF
06/28/2012US20120165263 Bone regeneration agent comprising gelatin
06/28/2012US20120165257 Compositions and methods for treating joints
06/28/2012US20120165255 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/28/2012US20120165254 Sulphated hyaluronic acid for treating degenerative osteoarthritis
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120164637 Susceptibility to bone damage
06/28/2012US20120164222 Novel compounds and compositions and methods of use
06/28/2012US20120164187 bioactive glass for use in conditions relating to bone infections
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
06/28/2012US20120164142 Compositions comprising natriuretic peptides and methods of use thereof
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164113 Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
06/28/2012US20120164075 Endoxifen methods and compositions in the treatment of mammalian diseases
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012CA2822263A1 Methods and compositions for preventing and treating osteoarthritis
06/28/2012CA2762340A1 Compositions and methods for treating joints
06/27/2012EP2467170A1 Vesicular formulations
06/27/2012EP2467160A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state
06/27/2012EP2225252B1 C2-c5-alkyl-imidazole-bisphosphonates
06/27/2012EP2215089B1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
06/27/2012EP2188263B1 Benzimidazole derivatives used as fxr agonists
06/27/2012EP2009992B1 Il-8 receptor antagonists
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012CN102517252A Biological materials and uses thereof
06/27/2012CN102516263A Spirotricyclic compound, its preparation method, and pharmaceutical composition containing it as well as application thereof
06/27/2012CN102516247A A-type calcium L-5-methyltetrahydrofolate polymorphism and preparation method thereof
06/27/2012CN102516241A CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
06/27/2012CN102516170A Amide derivatives
06/27/2012CN102512635A Chinese medicine mixture and application thereof and preparing method of Chinese medicine composition and Chinese medicine mixture
06/27/2012CN102512625A External paste for treating traumatic injury
06/27/2012CN102512601A Traditional Chinese medicine recipe for treating rheumatoid arthritis
06/27/2012CN102512599A Concentrated soft capsules for treating gout and preparation method thereof
06/27/2012CN102512588A Chinese medicine granular preparation for cow bone strengthening
06/27/2012CN102512574A Traditional Chinese medicine composition for treating animal rickets, its preparation method and its application
06/27/2012CN102512559A Chinese medicinal composition for treating scapulohumeral periarthritis
06/27/2012CN102512557A Traditional Chinese medicine for mid-late period recovery from trauma
06/27/2012CN102512545A Submicron powder bazheng powder normal temperature preparation method and special bidirectional airflow sieving machine thereof
06/27/2012CN102512543A Chinese medicinal composition for treating rheumatoid arthritis
06/27/2012CN102512530A Externally applied traditional Chinese medicine for treating acute closed sports injury
06/27/2012CN102512528A Chinese medicinal composition for promoting osteoporotic fracture healing
06/27/2012CN102512526A Medicine for treating early bone injury and soft tissue injury
06/27/2012CN102512523A Medicine for treating rheumatoid arthritis
06/27/2012CN102512519A Medicinal moxa roll for treating osteoporosis and preparation method thereof
06/27/2012CN102512517A Traditional Chinese medicine composition for treating bone fracture
06/27/2012CN102512510A Cervical vertebra health care product
06/27/2012CN102512505A Chinese patent medicine for treating bone spur
06/27/2012CN102512499A External application preparation for traumatology bone knitting, and preparation method thereof
06/27/2012CN102512488A Application of kudzu root in preparation of medicament for preventing and treating osteoporosis
06/27/2012CN102512421A Novel application of piperazine acidamide compound in pharmacy
06/27/2012CN102125645B Traditional Chinese medicine preparation for treating osteoporosis
06/27/2012CN102119989B Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis
06/27/2012CN102028922B Arthritis ointment
06/27/2012CN101972333B Medicament for eliminating turbid urines
06/27/2012CN101912572B Multi-effect external plaster
06/27/2012CN101912402B Composition of cefazedone sodium sterile and clavulanate potassium and proportion thereof
06/27/2012CN101884702B Joint adhesion treatment ointment
06/27/2012CN101879227B Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof
06/27/2012CN101850105B Cefuroxime sodium composite medicine
06/27/2012CN101850103B Clindamycin phosphate composite medicine
06/27/2012CN101810747B Chinese medicinal preparation for treating cervical spondylosis and lumbar disc herniation
06/27/2012CN101773577B Kanto tea bath package for curing rheumatism, arthritis and senile degenerative joint diseases
06/27/2012CN101703596B Medicinal liquor for treating pains and other diseases caused by hyperosteogeny
06/27/2012CN101669988B Extraction process of clerodendranthus spicatus
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101496849B Chinese medicine preparation for treating atrophic arthritis
06/27/2012CN101181386B Chinese medicine composition for curing bone fracture
06/27/2012CN101010087B High yield and rapid synthesis method for processing organic metal salt
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8207223 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2503211C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
06/26/2012CA2468082C Assay for screening candidate drugs for the treatment of inflammatory diseases
06/26/2012CA2443857C Bisphosphonate conjugates and methods of making and using the same
06/21/2012WO2012082573A1 Predictive methods and methods of treating arthritis using il-17 antagonists
06/21/2012WO2012082014A2 "mitsephosphon" pharmaceutical composition for stimulating the regeneration of supporting tissues
06/21/2012WO2012082013A2 "mitseostin" pharmaceutical composition for stimulating the regeneration of supporting tissue and articular cartilage (embodiments)
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 820